Applied Therapeutics, Inc.
APLT
$0.5153
$0.00120.23%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 26.62% | -32.99% | |||
| Gross Profit | -26.62% | 32.99% | |||
| SG&A Expenses | -25.51% | -17.06% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -9.51% | -22.70% | |||
| Operating Income | 9.51% | 22.70% | |||
| Income Before Tax | 2.27% | -149.59% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 2.27% | -149.59% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 2.27% | -149.59% | |||
| EBIT | 9.51% | 22.70% | |||
| EBITDA | 9.51% | 22.70% | |||
| EPS Basic | 2.46% | -149.47% | |||
| Normalized Basic EPS | 2.44% | -149.47% | |||
| EPS Diluted | 0.46% | -149.95% | |||
| Normalized Diluted EPS | 2.44% | -149.47% | |||
| Average Basic Shares Outstanding | 0.21% | 0.23% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.23% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||